Navigation Links
Metals could forge new cancer drug
Date:10/18/2009

Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.

The study, published in the Journal of Medicinal Chemistry, showed that a range of compounds containing the two transition metals Ruthenium and Osmium, which are found in the same part of the periodic table as precious metals like platinum and gold, cause significant cell death in ovarian and colon cancer cells.

The compounds were also effective against ovarian cancer cells which are resistant to the drug Cisplatin, the most successful transition metal drug, which contains the metal platinum.

Dr Patrick McGowan, one of the lead authors of the research from the School of Chemistry at the University of Leeds, explains: "Ruthenium and Osmium compounds are showing very high levels of activity against ovarian cancer, which is a significant step forward in the field of medicinal chemistry.

Sabine H. van Rijt, lead researcher in the laboratory of Professor Peter Sadler in the Department of Chemistry at the University of Warwick, said:

"Most interestingly, cancerous cells that have shown resistance to the most successful transition metal drug, Cisplatin, show a high death rate with these new compounds."

Professor Sadler, at the University of Warwick, commented that he is "excited by the novel design features in these compounds which might enable activity to be switched on and off".

Cisplatin was discovered in the 1970s and is one of the most effective cancer drugs on the market, with a 95% cure rate against testicular cancer. Since the success of Cisplatin, chemists all over the world have been trying to discover whether other transition metal compounds can be used to treat cancer.

In this type of anti cancer drug transition metal atoms bind to DNA molecules which trigger apoptosis, or programmed cell death, in the cancerous cells.

The study is a collaboration between the universities of Warwick and Leeds and was funded by the Engineering and Physical Sciences Research Council (EPSRC).


'/>"/>

Contact: Peter Dunn
p.j.dunn@warwick.ac.uk
44-077-676-55860
University of Warwick
Source:Eurekalert  

Related medicine news :

1. Heavy Metals Can Taint Wine
2. New sensor system improves detection of lead, heavy metals
3. Biosensors to probe the metals menace
4. New laryngoscope could make difficult intubations easier
5. Findings about veracity of peripheral vision could lead to better robotic eyes
6. Social Security COLA: Tomorrows Zero COLA Announcement for 2010 Could Cost Average Senior $10,134
7. Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges
8. Severe Swine Flu Could Lead to Blood Clots in Lungs: Study
9. A Gene Tweak Could Keep Heart Young
10. Increased levels of Muellerian-inhibiting substance could mean greater breast cancer risk
11. Cows Milk Protein Could Help Save Preemies Lives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Metals could forge new cancer drug
(Date:7/21/2017)... ... July 21, 2017 , ... The ... services to families and business owners in the Dalton region, is working in ... children overcoming sexual assault and physical abuse. , The GreenHouse is headquartered in ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... recently were selected to renovate and improve the Ramsey County Medical Examiners Facility ... to Regions Hospital, the $2.5 million project is scheduled to start in late ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand ... Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is ...
(Date:7/21/2017)... Grants Pass, OR (PRWEB) , ... July 21, ... ... that in recent weeks Nature’s Tears® EyeMist®, the signature product of her research ... the country with the world’s largest population and the greatest number of sufferers ...
(Date:7/20/2017)... Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... when placed between two clips in the FCPX timeline. This effect isolates horizontal and ... transition in this package contains either a rotating or flipping animation and can be ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
(Date:6/20/2017)... CHICAGO , June 19, 2017  Hill-Rom Holdings, Inc. ... conference call and webcast on Friday, July 28, 2017, beginning ... Conference Call Audio Only Dial-in information: To participate in the ... Please dial into the call at least 10 minutes prior ... Code is 34090339.  ...
Breaking Medicine Technology: